Alan Bash
Patrimonio netto: 178 105 $ in data 31/08/2026
Patrimonio netto: 178 105 $ in data 31/08/2026
Mr. Alan S.
Bash is a President-Carvykti at Legend Biotech Corp.
Mr. Bash was previously employed as a Chief Executive Officer & Director by ZielBio, Inc., a President & Chief Executive Officer by Checkmate Pharmaceuticals, Inc., and a Senior Vice President-Commercial Model Innovation by Bristol Myers Squibb Co. He received his undergraduate degree from Georgetown University and an MBA from Columbia Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,01% | 14/08/2026 | 17.142 ( 0,01% ) | 178 105 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Corporate Officer/Principal | 15/09/2026 |
| Società | Posizione | Fine |
|---|---|---|
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Amministratore Delegato | 01/10/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| CHECKMATE PHARMACEUTICALS, INC. | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale